Brought to you by:
The Golden Larva syndrome: Is it real?
Failure is part of the process that leads to success. Occasional failures may sting but we must recognize the adage that failure is a “bruise, not a tattoo.” I knew a mid-career faculty member some years ago who was rapidly…
Nectero Medical receives FDA clearance of IND application to initiate Phase II/III clinical trial of Nectero EAST system
Nectero Medical today announced that the US Food and Drug Administration (FDA) has granted investigational new drug (IND) clearance for the company to initiate a prospective, multicentre, randomised clinical trial (the stAAAble study) to evaluate the safety and efficacy of…
Endologix announces first patients treated with the Detour system
Endologix has shared in a press release that the first patients underwent percutaneous transmural arterial bypass (PTAB) using the Detour system since Food and Drug Administration (FDA) approval of the system was granted. PTAB with the Detour system treats complex peripheral…
SVS coding workshop coming in October
The SVS’ 2023 Coding and Reimbursement Workshop will help participants learn about accurate coding and reimbursement for vascular surgery. The intensive two-day program will review essential topics such as recent Current Procedural Terminology (CPT) code and Medicare changes. An optional…
Crawford panel looks at opportunities to plug and extend vascular surgery workforce pipeline
This year’s E. Stanley Crawford Critical Issues Forum zeroed in on the pipeline of sources feeding the vascular surgery ranks. Incoming SVS President Joseph Mills, MD, assembled an expert panel to look at many of the key issues at the…
SVS responds to New York Times article on overuse of vascular interventions
In an official Society response, SVS President Joseph Mills, MD, tackles recent coverage in the mainstream media of inappropriateness in vascular care. There have been several recently published articles by respected news media outlets highlighting the deeply concerning issue of…
The numbers are in: VAM 2023 adds up to another SVS classic
Landmark meeting (June 14-17) with nearly 1,400 vascular professionals moves the needle with program innovations, slew of new science and jam-packed agenda. With more content presented than ever before, a family-friendly Wednesday night gathering, the inaugural Frank J. Veith Distinguished…
Second edition of VSITE review text released
The second edition of a hit trainee-created textbook primarily aimed at those taking the Vascular Surgery In-Training Exam (VSITE) has hit the shelves. The Vascular Surgery Review Book, authored by Thomas Creeden, DO, a resident from the University of Massachusetts in Worcester,…
SVS seeks volunteers to write position paper
Society for Vascular Surgery (SVS) members have until July 31 to apply to serve on a new SVS writing group to develop a position paper on the scope of work of vascular surgery practice in diagnosing and treating vascular disease.…
Study finds similar rates of VTE in both flying and non-flying surgical patients
Uncertainty underlying the magnitude of risk posed by long distance air travel in venous thromboembolism (VTE) patients has created the need for a deeper, systematic dive into the guidelines and resources providers should be turning to when managing their pre-flight…